NewsRoom Articles - Page 152 of 610

MondayDec 12, 2022 4:20 am

420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana

Last week, the Marijuana Enforcement Division in the state of Colorado announced that cannabis grown under a medical cultivation permit could be recategorized as retail products and sold in adult-use shops. The division, which is tasked with the licensing and regulation of medical and retail cannabis industries in the state, also announced new safety protections for employees involved in the manufacture of marijuana. Workers who take part in a range of manufacturing tasks will now be required to wear goggles and masks as well as respirators. Other announcements included the news that the eligibility period for would-be social equity licensees…

FridayDec 09, 2022 4:20 pm

420 with CNW — NJ Regulators OK Cannabis Consumption Lounge Rules

Marijuana industry regulators in the state of New Jersey have approved regulations for “public marijuana consumption areas,” taking the state a step closer to permitting social consumption for patients and adults. Shops selling marijuana opened their doors this April, but advocates are insisting on the necessity of establishing regulations that would accord users more spaces for lawful cannabis consumption. Recently, New Jersey's Cannabis Regulatory Commission (CCR) moved close to achieving this when they approved requirements to oversee the consumption venues as well as fees that businesses which operate those sites have to pay. Currently Cannabis is accessible to everyone 21…

FridayDec 09, 2022 4:20 am

420 with CNW — Michigan Resident Files Lawsuit Against California’s Marijuana Social Equity Law

Kenneth Gay, a Michigan resident, has filed a lawsuit challenging the constitutionality the cannabis social equity program in Los Angeles. Gay has a stake in an LA-based company and had applied for a license under the social equity program. According to the suit, Gay has submitted his social equity application, but as of October 24, 2022, the City of Los Angeles hadn’t completed verifying his eligibility and yet a lottery to select licensees is slated for Dec. 8, 2022. He filed his lawsuit on Nov. 30, 2022. Under LA law, to be eligible for the social equity program permit, one…

ThursdayDec 08, 2022 4:20 pm

420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients

New research has found that the legalization of medical cannabis has been linked to a reduction in the use and prescription of opioids for patients with cancer. The research involved a cross-section analysis of data on insurance claims from more than 38,000 individuals who had recently been diagnosed with cancer. The analysis included 34 states and was carried out by researchers at the University of Texas, Harvard University, Albert Einstein College of Medicine and Weill Medical College of Cornell University. The researchers’ objective was to examine how the existence of more cannabis dispensaries influenced opioid prescription. Researchers discovered that medical…

ThursdayDec 08, 2022 9:45 am

Improving Loan Origination Landscape is Positive News for Mortgage Loan Clients, Mortgage Loan Facilitator REZYFi, Inc.

Miami-based REZYFi is a mortgage lender working with traditional loans but focusing particular attention on unbanked market sectors such as the cannabis industry and those property companies that provide leases to those sectors The loan origination industry appears to be experiencing a new round of greening in reversal of the year’s difficulties In the wake of positive CPI data last month, analysts are beginning to anticipate a greening of mortgage lending rates once inflationary pressures are reduced, making it easier for companies to obtain loans for their projects The greening of inflation news last month is important news for market…

ThursdayDec 08, 2022 4:20 am

420 with CNW — President Biden Enacts Cannabis Research Bill

U.S. President Joe Biden made history when he enacted the cannabis research bill and signed it into law on Nov. 2, 2022. The law now waits for 60 days for the attorney general to either approve it or ask for supplementary information from the originator of the bill. This new law opens the gates for further extensive research on marijuana to be done. The use of cannabis is prohibited federally in the United States except for FDA-approved research. Specific states have, however, enacted legislation permitting the plant or its derivatives for research, medical, industrial and or recreational purposes. President Biden…

WednesdayDec 07, 2022 4:20 pm

420 with CNW — New Applications for Federal Positions Won’t Require Cannabis Use History

More than two decades after California first legalized medical cannabis, dozens of states now have their own medical and recreational cannabis markets. The cannabis industry generates billions of dollars in sales every year, proving that cannabis is one of the most popular drugs in the country even as states have loosened their policies. However, the federal government still considers cannabis a Schedule I controlled substance, meaning that even though qualifying individuals are allowed to take part in state-legal cannabis markets, their actions remain illegal at the federal level. As a result, cannabis consumers often find themselves penalized for purchasing and…

WednesdayDec 07, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Findings of Animal Anti-Seizure Study Program Suggesting that DehydraTECH(TM)-CBD Is More Effective at Lower Doses and Works More Rapidly than FDA-Approved Epidiolex

Lexaria recently announced the findings of the first two studies from its EPIL-A21-1 animal research program The program is designed to assess the effectiveness of patented DehydraTECH(TM)-CBD in reducing or eliminating seizure activity compared to Epidiolex, a CBD-based anti-seizure drug The first study evidenced that DehydraTECH-CBD is more efficacious at lower doses than Epidiolex The second study demonstrated DehydraTECH-CBD’s enhanced effectiveness; specifically, the formulation acted more rapidly than Epidiolex Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) formulation has demonstrated performance enhancements compared to Epidiolex(R), the first and only FDA-approved…

WednesdayDec 07, 2022 4:20 am

420 with CNW — Minnesota Expands List of Qualifying Conditions for Medical Cannabis

The Department of Health in Minnesota has approved the addition of obsessive compulsive disorder (OCD) and irritable bowel syndrome (IBS) to the list of medical conditions for which patients can be certified to start using medical marijuana. This change is slated for implementation starting on Aug. 1, 2023. Jan Malcolm, the state’s health commissioner, said that the health department was adding OCD and IBS to the list of qualifying conditions so that the patients suffering from these two conditions, which are debilitating, could have access to an expanded pool of treatment options to manage their medical conditions. People who suffer…

TuesdayDec 06, 2022 4:20 pm

420 with CNW — Ohio Campaigners Look to 2023 Ballot to Legalize Adult-Use Marijuana

Cannabis reform activists in the state of Ohio are hoping to get a recreational cannabis legalization bill on the November 2023 ballot. Earlier this year, the campaign behind a legalization measure announced that the bill would not be on the 2022 ballot but that there was a chance of getting the measure on the subsequent year’s ballot. The Coalition to Regulate Marijuana Like Alcohol had filed a complaint for declaratory judgment in April to ensure that the measure made it onto last month’s ballot. The suit was unsuccessful, however, and the coalition reached an agreement with legislative leaders and the…

News and publishing service for cannabis related companies

Contact us: 512.354.7000